CI Canadian Convertible Bond ETF Common (TSE:CXF – Get Free Report) shares shot up 1% during trading on Tuesday . The company traded as high as C$10.23 and last traded at C$10.23. 6,600 shares changed hands during trading, an increase of 55% from the average session volume of 4,251 shares. The stock had previously closed at C$10.13.
CI Canadian Convertible Bond ETF Common Stock Performance
The stock has a 50-day simple moving average of C$10.19 and a 200 day simple moving average of C$10.10.
CI Canadian Convertible Bond ETF Common Company Profile
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company’s approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
Further Reading
- Five stocks we like better than CI Canadian Convertible Bond ETF Common
- 3 Best Fintech Stocks for a Portfolio Boost
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Using the MarketBeat Stock Split Calculator
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for CI Canadian Convertible Bond ETF Common Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Canadian Convertible Bond ETF Common and related companies with MarketBeat.com's FREE daily email newsletter.
